National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 35176 [2014-14301]

Download as PDF 35176 Federal Register / Vol. 79, No. 118 / Thursday, June 19, 2014 / Notices Dated: June 13, 2014. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2014–14298 Filed 6–18–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings emcdonald on DSK67QTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Clinical Research in Prevention, Diagnosis, and Treatment of HIV-Related Heart, Lung, and Blood Diseases (R01). Date: August 1, 2014. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Crystal Gateway Marriott, 1700 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Tony L. Creazzo, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892–7924, 301–435– 0725 creazzotl@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Basic Research in the Pathogenesis of HIVRelated Heart, Lung, and Blood Diseases (R01). Date: August 6, 2014. Time: 8:30 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: Crystal Gateway Marriott, 1700 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Tony L. Creazzo, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892–7924, 301–435– 0725 creazzotl@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Basic Research in the Pathogenesis of HIV- VerDate Mar<15>2010 17:25 Jun 18, 2014 Jkt 232001 Related Heart, Lung, and Blood Diseases (R21). Date: August 6, 2014. Time: 1:30 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Crystal Gateway Marriott, 1700 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Tony L. Creazzo, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892–7924, 301–435– 0725 creazzotl@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: June 12, 2014. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–14301 Filed 6–18–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information: The National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods Requests Data and Information on Devices and/or Technologies Used for Identifying Potential Inhalation Hazards The National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) requests available data and information on devices and/or technologies currently used for identifying potential inhalation hazards. Submitted information will be used to assess the state of the science and determine the technical needs for a dynamic nonanimal system to assess the potential toxicity of inhaled chemicals and nanomaterials. DATES: The deadline for receipt of information is July 18, 2014. ADDRESSES: Data and information should be submitted electronically to niceatm@niehs.nih.gov. FOR FURTHER INFORMATION CONTACT: Dr. Warren S. Casey, Director, NICEATM; email: warren.casey@nih.gov; telephone: (919) 316–4729. SUPPLEMENTARY INFORMATION: Background: NICEATM fosters the evaluation and promotion of alternative test methods for regulatory use in acute SUMMARY: PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 toxicity assessment. Efforts to date have focused primarily on assessing test methods for oral and dermal hazards with limited efforts directed towards identifying alternatives for inhalation toxicity assessment. NICEATM is interested in receiving information on the state of the science regarding alternative test methods and testing strategies for acute or sub-chronic inhalation toxicity. This information will be used to determine the technical requirements for developing effective inhalation toxicity tools to assess potential chemical and nanomaterial hazards without the use of animals in testing. Request for Information: NICEATM requests available data and information on devices and/or technologies currently used to identify potential inhalation hazards. To that end, NICEATM requests that respondents provide information on any activities relevant to the development or validation of alternatives to in vivo inhalation toxicity test methods currently required by regulatory agencies, including submission of substance-specific data derived from non-animal tests to identify acute or sub-chronic inhalation hazard potential. If available, corresponding in vivo data obtained for these substances are also requested, including data from any ethical human or animal studies or accidental human exposures. Respondents to this request for information should include their name, affiliation (if applicable), mailing address, telephone, email, and sponsoring organization (if any) with their communications. The deadline for receipt of the requested information is July 18, 2014. Responses to this notice will be posted at https:// ntp.niehs.nih.gov/go/41624 and persons submitting them will be identified by name and affiliation or sponsoring organization, if applicable. Responses to this request are voluntary. No proprietary, classified, confidential, or sensitive information should be included in responses. This request for information is for planning purposes only and is not a solicitation for applications or an obligation on the part of the U.S. Government to provide support for any ideas identified in response to the request. Please note that the U.S. Government will not pay for the preparation of any information submitted or for its use of that information. Background Information on NICEATM: NICEATM conducts data analyses, workshops, independent validation studies, and other activities to assess new, revised, and alternative E:\FR\FM\19JNN1.SGM 19JNN1

Agencies

[Federal Register Volume 79, Number 118 (Thursday, June 19, 2014)]
[Notices]
[Page 35176]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14301]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Clinical Research in Prevention, Diagnosis, 
and Treatment of HIV-Related Heart, Lung, and Blood Diseases (R01).
    Date: August 1, 2014.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crystal Gateway Marriott, 1700 Jefferson Davis Highway, 
Arlington, VA 22202.
    Contact Person: Tony L. Creazzo, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 
20892-7924, 301-435-0725 creazzotl@mail.nih.gov.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Basic Research in the Pathogenesis of HIV-
Related Heart, Lung, and Blood Diseases (R01).
    Date: August 6, 2014.
    Time: 8:30 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crystal Gateway Marriott, 1700 Jefferson Davis Highway, 
Arlington, VA 22202.
    Contact Person: Tony L. Creazzo, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 
20892-7924, 301-435-0725 creazzotl@mail.nih.gov.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Basic Research in the Pathogenesis of HIV-
Related Heart, Lung, and Blood Diseases (R21).
    Date: August 6, 2014.
    Time: 1:30 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crystal Gateway Marriott, 1700 Jefferson Davis Highway, 
Arlington, VA 22202.
    Contact Person: Tony L. Creazzo, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 
20892-7924, 301-435-0725 creazzotl@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: June 12, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-14301 Filed 6-18-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.